Adam Foley‐Comer - Concepedia

Author

Adam Foley‐Comer

Also Known As

A. Foley-Comer, Adam Foley-Comer, Adam Foley‐Comer, Adam J Foley-Comer, Adam J. Foley-Comer, Foley-Comer, Adam

Publications

315

Citations

H-Index

Concepts

All Affiliations

Adam Foley‐Comer is an author at Hebrew University of Jerusalem specializing in matrix biology, developmental biology, and extracellular matrix.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	58
2	Cell Biology	1	1	58
3	Cellular Physiology	1	1	58
4	Cell Signaling	1	1	58
5	Developmental Biology	1	1	58

Adam Foley‐Comer

Publications

290

Citations

H-Index

Page 1

	Year	Citations
Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing Adam Foley‐Comer, Sarah E. Herrick, Talib Al-Mishlab, Journal of Cell Science	2002	149
HGF/SF Induces Mesothelial Cell Migration and Proliferation by Autocrine and Paracrine Pathways R. M. Warn, P Harvey, A Warn, Experimental Cell Research Paracrine PathwaysDevelopmental BiologyCell SignalingCell MigrationCell Proliferation	2001	58
BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study Gautam Borthakur, Yishai Ofran, Martin S. Tallman, Cancer	2020	37
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity Ewa Cendrowicz, Lisa Jacob, Shirley Greenwald, Journal of Experimental & Clinical Cancer Research	2022	22
BL-8040, a Peptidic CXCR4 Antagonist, Induces Leukemia Cell Death and Specific Leukemia Cell Mobilization in Relapsed/Refractory Acute Myeloid Leukemia Patients in an Ongoing Phase IIa Clinical Trial Gautam Borthakur, Arnon Nagler, Yishai Ofran, Blood	2014	14
Abstract A076: DSP107—a novel SIRPα-4-1BBL dual signaling protein (DSP) for cancer immunotherapy Yosi Gozlan, Susan Hilgendorf, Alexandra Aronin, Cancer Immunology Research	2019	10

Page 1